Bridgeway Capital Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$31.23 - $42.99 $1.1 Million - $1.52 Million
35,360 New
35,360 $1.19 Million
Q2 2020

Aug 14, 2020
SELL
$12.66 - $58.27 $530,454 - $2.44 Million
-41,900 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$8.93 - $12.41 $16,967 - $23,579
1,900 Added 4.75%
41,900 $455,000
Q3 2019

Nov 14, 2019
BUY
$8.8 - $14.5 $352,000 - $580,000
40,000 New
40,000 $411,000

Others Institutions Holding ARCT

# of Institutions
178
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $478M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email